Phase 1/2 Obesity clinical trials

11 recruiting Phase 1/2 obesity studies in the US. What trial phases mean

Other phases

RecruitingPhase 1 / Phase 2NCT07123779

HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction

Sponsor: 35Pharma Inc

Kansas City, MO · Greenville, SC

RecruitingPhase 1 / Phase 2NCT05972564

The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function

Sponsor: Vanderbilt University Medical Center

Nashville, TN

RecruitingPhase 1 / Phase 2NCT06836609

A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)

Sponsor: Regeneron Pharmaceuticals

Chandler, AZ · Tucson, AZ

RecruitingPhase 1 / Phase 2NCT06842186

A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity

Sponsor: Wave Life Sciences USA, Inc.

Baltimore, MD

RecruitingPhase 1 / Phase 2NCT06755827

Pilot Testing a Novel Approach to Pediatric Obesity Treatment

Sponsor: Texas Tech University

Lubbock, TX

RecruitingPhase 1 / Phase 2NCT05746039

Feasibility of Semaglutide in Advanced Lung Disease

Sponsor: University of Pennsylvania

Philadelphia, PA

RecruitingPhase 1 / Phase 2NCT05312892

Sympathetic Mechanisms in Obesity-Crossover Design

Sponsor: Vanderbilt University Medical Center

Nashville, TN

RecruitingPhase 1 / Phase 2NCT04328337

Investigating Whether Acute Elevation of Fatty Acid Levels Alters Cerebral Glucose Transport and Metabolism

Sponsor: University of North Carolina, Chapel Hill

Chapel Hill, NC

RecruitingPhase 1 / Phase 2NCT06817863

A Self-Guided Mobile Intervention for Adults With Binge Eating and Obesity

Sponsor: Drexel University

Philadelphia, PA

Not yet recruitingPhase 1 / Phase 2NCT07398404

A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

Sponsor: Medical University of South Carolina

Charleston, SC

Not yet recruitingPhase 1 / Phase 2NCT07642635

Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy

Sponsor: Vanderbilt University Medical Center

Nashville, TN

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.